ARIAD to Present at the CITI 2011 Global Healthcare Conference

Show Health and Fitness Publications

Mon, February 28, 2011

[ Mon, Feb 28th 2011 ] - Market Wire

Amyris Reports Fourth Quarter and 2010 Year-End Results

[ Mon, Feb 28th 2011 ] - Market Wire

Ironwood Pharmaceuticals to Host Fourth Quarter 2010 Investor Update Call

[ Mon, Feb 28th 2011 ] - Market Wire

Aetna, OSS Orthopaedic Hospital Reach Agreement

[ Mon, Feb 28th 2011 ] - Market Wire

Kendall Law Group Investigates Forest Laboratories, Inc. for Shareholders

[ Mon, Feb 28th 2011 ] - Market Wire

Inhibitex to Host Conference Call to Report Fourt .. Year-End 2010 Financial Results on March 11, 2011

[ Mon, Feb 28th 2011 ] - Market Wire

GTSO to Coordinate New Rare Earth Exports at Mongolian Embassy in DC this Week

[ Mon, Feb 28th 2011 ] - Market Wire

BIOLASE Announces Successful Showing of Waterlase .. r at 146th Chicago Dental Society Midwinter Meeti

[ Mon, Feb 28th 2011 ] - Market Wire

Former-Deputy Surgeon General Canada Appointed President of Medizone International

[ Mon, Feb 28th 2011 ] - Market Wire

Amyris Sells First Renewable Product

[ Mon, Feb 28th 2011 ] - Market Wire

Amyris comercializa seu primeiro produto renovvel

[ Mon, Feb 28th 2011 ] - Market Wire

Thermo Fisher Scientific Announces Redemption of .. 5% Convertible Senior Subordinated Notes Due 2024

[ Mon, Feb 28th 2011 ] - Market Wire

FDA Grants Priority Review For ISTODAX® sNDA For Treatment of Progressive or Relapsed PTCL

[ Mon, Feb 28th 2011 ] - Market Wire

Derma Sciences Receives FDA Clearance for MEDIHONEY® Gel

[ Mon, Feb 28th 2011 ] - Market Wire

Implant Sciences Announces $600,000 in New Orders

[ Mon, Feb 28th 2011 ] - Market Wire

Cytori to Webcast Corporate Presentation at CitiB .. nce on March 2 Followed by Fourth Quarter Earning

[ Mon, Feb 28th 2011 ] - Market Wire

Seattle Genetics Submits BLA to FDA for Brentuxim .. or Refractory Hodgkin Lymphoma and Systemic ALCL

[ Mon, Feb 28th 2011 ] - Market Wire

Alcon meldt datum van jaarlijkse aandeelhoudersvergadering

Sun, February 27, 2011

[ Sun, Feb 27th 2011 ] - Market Wire

Forest Laboratories, Inc. and Gedeon Richter Plc .. II Study of Cariprazine as Adjunctive Therapy in

[ Sun, Feb 27th 2011 ] - Market Wire

Alcon Announces Date of Annual General Meeting

[ Sun, Feb 27th 2011 ] - Market Wire

Santarus and Pharming Announce Receipt of FDA Ref .. e Letter for RHUCIN Biologics License Application

[ Sun, Feb 27th 2011 ] - Market Wire

Fujifilm to Acquire Merck Biomanufacturing Network

Fri, February 25, 2011

[ Fri, Feb 25th 2011 ] - Market Wire

Quidel to Present at Citi 2011 Global Health Care Conference

[ Fri, Feb 25th 2011 ] - Market Wire

AngioDynamics Cancels Participation in 2011 RBC Capital Markets Healthcare Conference

[ Fri, Feb 25th 2011 ] - Market Wire

ISTA Pharmaceuticals to Present at 2011 RBC Capit .. ence and Cowen and Company's 31st Annual Health C

[ Fri, Feb 25th 2011 ] - Market Wire

Goldman Scarlato & Karon, P.C. Announces Investigation of Clinical Data, Inc.

[ Fri, Feb 25th 2011 ] - Market Wire

Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Clinical Data, Inc.

[ Fri, Feb 25th 2011 ] - Market Wire

Furiex Confirms Takeda Receives Approval of Addit .. rapies with Sulfonylurea and Biguanide for Type 2

[ Fri, Feb 25th 2011 ] - Market Wire

Medtronic Announces Purchase of Innovative Gel Te .. Use in Functional Endoscopic Sinus Surgery (FESS)

[ Fri, Feb 25th 2011 ] - Market Wire

Impax Laboratories to Present at the RBC Capital Marketsa? Healthcare Conference

[ Fri, Feb 25th 2011 ] - Market Wire

Cerus to Release Fourth Quarter and Year-End 2010 Results on March 3, 2011

[ Fri, Feb 25th 2011 ] - Market Wire

Osiris Therapeutics to Present at Citi 2011 Global Healthcare Conference

[ Fri, Feb 25th 2011 ] - Market Wire

Affymax to Present at RBC Capital Marketsa? Healthcare Conference

[ Fri, Feb 25th 2011 ] - Market Wire

Paulo Diniz Joins Amyris as CEO, Amyris Brasil

[ Fri, Feb 25th 2011 ] - Market Wire

Paulo Diniz Assume a Presidncia da Amyris Brasil

[ Fri, Feb 25th 2011 ] - Market Wire

Micromet to Report Fourth Quarter and Full Year 2010 Financial Results on March 3

[ Fri, Feb 25th 2011 ] - Market Wire

AMAG Announces Fourth Quarter and Year End 2010 Financial Results

[ Fri, Feb 25th 2011 ] - Market Wire

Trinity Biotech plc to Announce Fourth Quarter & Fiscal Year 2010 Financial Results

[ Fri, Feb 25th 2011 ] - Market Wire

DUSA Pharmaceuticals, Inc.® to Host Fourth Quart .. e Highlights and Financial Results Conference Cal

Thu, February 24, 2011

[ Thu, Feb 24th 2011 ] - Market Wire

Arena & Exelixis Face Difficult Approval Processes

[ Thu, Feb 24th 2011 ] - Market Wire

GTSO Pursues Rare Earth Transport Agreement with Russian Railways

[ Thu, Feb 24th 2011 ] - Market Wire

Marina Biotech Reports Interim Results of Their Phase 2-Enabling Toxicology Study for CEQ508

[ Thu, Feb 24th 2011 ] - Market Wire

Equity Research on OXiGENE Inc. and PDL BioPharma Inc. -- Biotechnology Sector Active Lately

[ Thu, Feb 24th 2011 ] - Market Wire

Antrim Energy Inc. Announces $45 Million Bought Deal Financing

[ Thu, Feb 24th 2011 ] - Market Wire

Amyris Partners with Givaudan to Develop Key Fragrance Ingredient from Biofene

[ Thu, Feb 24th 2011 ] - Market Wire

MEDIA ADVISORY - Oncolytics Biotech® Inc. to .. sent at RBC Capital Markets Healthcare Conference

[ Thu, Feb 24th 2011 ] - Market Wire

Continucare Corporation to Present at the 2011 RBC Capital Markets' Healthcare Conference

[ Thu, Feb 24th 2011 ] - Market Wire

Given Imaging to Present at RBC Capital Markets' Healthcare Conference

[ Thu, Feb 24th 2011 ] - Market Wire

Inspire Announces Webcast of Presentation at Citi Global Healthcare Conference

[ Thu, Feb 24th 2011 ] - Market Wire

Salix Anticipates Receipt of FDA Complete Respons .. 550 Mg Tablets Supplemental New Drug Application

[ Thu, Feb 24th 2011 ] - Market Wire

Magellan Health Services Reports Fourth Quarter and Full Year 2010 Financial Results

[ Thu, Feb 24th 2011 ] - Market Wire

Thermo Fisher Scientific Signs Agreements to Sell .. aster Laboratories Businesses for a Total of $940

[ Thu, Feb 24th 2011 ] - Market Wire

Exelixis Announces March 1 Webcast of Presentation at the Citi 2011 Global Health Care Conference

[ Thu, Feb 24th 2011 ] - Market Wire

ICON Reports Full-Year 2010 Revenue of $900m and EPS of $1.44

[ Thu, Feb 24th 2011 ] - Market Wire

Aetna Launches New International Health Plans to Make Health Care Accessible and Affordable

[ Thu, Feb 24th 2011 ] - Market Wire

Aetna????????????,???????????????????????

Wed, February 23, 2011

[ Wed, Feb 23rd 2011 ] - Market Wire

AmSurg Corp. to Present at the Citi 2011 Global Health Care Conference

[ Wed, Feb 23rd 2011 ] - Market Wire

BrainStorma?s NurOwna" Stem Cell Technology Shows Promise for Treating Sciatic Nerve Injury

[ Wed, Feb 23rd 2011 ] - Market Wire

LabCorp is Scheduled to Speak at RBC Capital Marketsa? 2011 Healthcare Conference

[ Wed, Feb 23rd 2011 ] - Market Wire

Dynavax's Two Phase 3 HEPLISAV Trials Cleared by DSMB to Continue to Study Completion

[ Wed, Feb 23rd 2011 ] - Market Wire

BIOLASE Announces Unaudited Fourth Quarter Net In .. Share and Non-GAAP Net Income of $0.03 per Share

[ Wed, Feb 23rd 2011 ] - Market Wire

Radient Pharmaceuticals Announces Appointment of .. Robert L. Rooks DVM, MS to Its Board of Directors

[ Wed, Feb 23rd 2011 ] - Market Wire

Unigene to Present at the 9th Annual BioPartnering North Americaa" Conference on March 1, 2011

[ Wed, Feb 23rd 2011 ] - Market Wire

Oncolytics Biotech® Inc. Announces Completio .. nal Clinical Trial Investigating REOLYSIN® i

[ Wed, Feb 23rd 2011 ] - Market Wire

Covidien to Present at Upcoming Investor Conferences

[ Wed, Feb 23rd 2011 ] - Market Wire

GTx Announces Webcast of Corporate Presentation at the Citi 2011 Global Health Care Conference

[ Wed, Feb 23rd 2011 ] - Market Wire

Phase 3 Study of VX-770 Showed Profound and Susta .. nction (FEV1) and Other Measures of Disease Among

[ Wed, Feb 23rd 2011 ] - Market Wire

AngioDynamics to Present at the 2011 RBC Capital Markets Healthcare Conference

[ Wed, Feb 23rd 2011 ] - Market Wire

Synergy Pharmaceuticals ottiene il brevetto ameri .. in fase di sviluppo per le malattie infiammatori

[ Wed, Feb 23rd 2011 ] - Market Wire

Synergy Pharmaceuticals obtient un brevet am©ric .. nt en cours de d©veloppement de Synergy pour les

[ Wed, Feb 23rd 2011 ] - Market Wire

Amerikaans patent verleend aan Synergy Pharmaceut .. middel in ontwikkeling voor gastro-intestinale on

[ Wed, Feb 23rd 2011 ] - Market Wire

Synergy Pharmaceuticals erhlt US-Patent fr seinen .. P-333 zur Behandlung entzndlicher Darmkrankheiten

[ Wed, Feb 23rd 2011 ] - Market Wire

Synergy Pharmaceuticals Granted U.S. Patent on SP .. l Drug for Gastrointestinal Inflammatory Diseases

Tue, February 22, 2011

[ Tue, Feb 22nd 2011 ] - Market Wire

Community Health Systems to Participate in the Citi 2011 Global Healthcare Conference

[ Tue, Feb 22nd 2011 ] - Market Wire

Wright Medical Group, Inc. to Participate in Upcoming 2011 Healthcare Conferences

[ Tue, Feb 22nd 2011 ] - Market Wire

Hi-Tech Pharmacal Receives Final Approval and 180 .. y Market Exclusivity for Gabapentin Oral Solution

[ Tue, Feb 22nd 2011 ] - Market Wire

Opexa CEO Invited as Keynote Speaker at Cell Therapy Conference in Beijing, China

[ Tue, Feb 22nd 2011 ] - Market Wire

Secure eHealth Health Information Exchange Integr .. eroperability Showcase as Part of GSI Health Tech

[ Tue, Feb 22nd 2011 ] - Market Wire

Medisafe 1 Technologies Signs an LOI to Secure a .. From an Institutional Investor Managed by Roswel

[ Tue, Feb 22nd 2011 ] - Market Wire

PROTECT II Study Results Accepted for Presentation at 2011 ACC Show During Late Breaking Sessions

[ Tue, Feb 22nd 2011 ] - Market Wire

BioSante Pharmaceuticals, Inc. to Present at Citi Global Health Care Conference

[ Tue, Feb 22nd 2011 ] - Market Wire

POZEN Announces Addition to Commercial Team

[ Tue, Feb 22nd 2011 ] - Market Wire

Synta to Participate in Panel Titled Targeting Ke .. at the RBC Capital Markets Healthcare Conference

[ Tue, Feb 22nd 2011 ] - Market Wire

Chemed Corporationa?s Board of Directors Approves $100 Million Stock Repurchase Program

[ Tue, Feb 22nd 2011 ] - Market Wire

Biomoda Completes Patient Enrollment and Sample Collection for Pilot Study

[ Tue, Feb 22nd 2011 ] - Market Wire

PROTOX APPOINTS NEW DIRECTORS

[ Tue, Feb 22nd 2011 ] - Market Wire

FONAR Announces Second Quarter, Fiscal 2011, Fina .. of $1.4 Million and Six Months Net Income of $1.

[ Tue, Feb 22nd 2011 ] - Market Wire

Given Imaging's SensorBelt Available to More Patients

[ Tue, Feb 22nd 2011 ] - Market Wire

SuperGen to Announce 2010 Fourth Quarter and Year-End Financial Results on February 28, 2011

[ Tue, Feb 22nd 2011 ] - Market Wire

Pieris to Present Interim Data From the Phase I C .. l of PRS-050 at Molecular Medicine Tri-Conference

Mon, February 21, 2011

[ Mon, Feb 21st 2011 ] - Market Wire

Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional

[ Mon, Feb 21st 2011 ] - Market Wire

Santarus and Pharming Announce Initiation of Phas .. Study with RHUCIN in Acute Hereditary Angioedema

[ Mon, Feb 21st 2011 ] - Market Wire

Assisted Living Concepts, Inc. Enters Into New $1 .. - Substantially Reduces Collateralized Residences

[ Mon, Feb 21st 2011 ] - Market Wire

Sanofi Pasteur and International Vaccine Institute Partner Against Dengue

Sun, February 20, 2011

[ Sun, Feb 20th 2011 ] - Market Wire

LifeWatch Teams With UnitedHealthcare, The Larges .. nited States, As A Preferred National Provider Of

Fri, February 18, 2011

[ Fri, Feb 18th 2011 ] - Market Wire

Faruqi & Faruqi, LLP Announces Shareholder Invest .. e Acquisition of Emergency Medical Services - EMS

[ Fri, Feb 18th 2011 ] - Market Wire

Largest Study of Medtronic CoreValve® System Confirms Positive Clinical Outcomes

[ Fri, Feb 18th 2011 ] - Market Wire

ISOTECHNIKA WELCOMES NEW BOARD MEMBERS

[ Fri, Feb 18th 2011 ] - Market Wire

00 a.m. ET to Discuss Financial Results for the Fourth Quarter and Year Ended 2010

[ Fri, Feb 18th 2011 ] - Market Wire

Impax Laboratories Receives Final FDA Approval for Generic Adoxa® 150 mg Capsules

[ Fri, Feb 18th 2011 ] - Market Wire

Chinese Minister Highlights Need for Rare Earth Suppliers Outside of China

[ Fri, Feb 18th 2011 ] - Market Wire

Schiff Nutrition International Appoints Tarang Amin as CEO

[ Fri, Feb 18th 2011 ] - Market Wire

Cerus Corporation Postpones Fourth Quarter & Year-End 2010 Earnings Release and Conference Call

[ Fri, Feb 18th 2011 ] - Market Wire

NOVAVAX Presents Final Results from H1N1 Influenz .. accine Trial at World Health Organization Meeting

[ Fri, Feb 18th 2011 ] - Market Wire

TomoTherapy Announces Fourth Quarter and Full Year Financial Results

Thu, February 17, 2011

[ Thu, Feb 17th 2011 ] - Market Wire

Regulatory Process Is an Ongoing Challenge for Xoma & BioSante

[ Thu, Feb 17th 2011 ] - Market Wire

Aeolus fecha contrato no valor total de US$118 mi .. lver tratamento de sndrome aguda de radiao pulmon

[ Thu, Feb 17th 2011 ] - Market Wire

InSite Vision to Report Fourth Quarter and Year-End 2010 Financial Results on February 24, 2011

[ Thu, Feb 17th 2011 ] - Market Wire

IMAGING DYNAMICS COMPANY ANNOUNCES NON BROKERED PRIVATE PLACEMENT

[ Thu, Feb 17th 2011 ] - Market Wire

United Treatment Centers, Inc. Resolves Trademark Lawsuit

[ Thu, Feb 17th 2011 ] - Market Wire

Micromet to Present at Two Upcoming Investor Conferences

[ Thu, Feb 17th 2011 ] - Market Wire

Vidaza ontvangt positieve Final Appraisal Determi .. for Health and Clinical Excellence (NICE) voor g

[ Thu, Feb 17th 2011 ] - Market Wire

CompCare Expands Contracts with Existing Clients

[ Thu, Feb 17th 2011 ] - Market Wire

ARIAD Reports Development Progress and Fourth Quarter and Year-End 2010 Financial Results

[ Thu, Feb 17th 2011 ] - Market Wire

St. Eugene Annouces Initial Mineral Resource at Amisk Gold Project

[ Thu, Feb 17th 2011 ] - Market Wire

Universal American Corp. Reports 2010 Fourth Quarter and Full Year Results

[ Thu, Feb 17th 2011 ] - Market Wire

Inspire Announces Corporate Restructuring and Strategic Focus on Eye Care Business

[ Thu, Feb 17th 2011 ] - Market Wire

Inspire Reports Fourth Quarter and Full Year 2010 Financial Results

[ Thu, Feb 17th 2011 ] - Market Wire

Vidaza® erhlt positive Final Appraisal Determina .. r Health and Clinical Excellence fr die Verwendun

[ Thu, Feb 17th 2011 ] - Market Wire

Vidaza® reoit un avis d©finitif positif de la p .. ealth and Clinical Excellence (NICE) pour tre uti

[ Thu, Feb 17th 2011 ] - Market Wire

Vidaza® ottiene valutazione finale positiva da p .. r Health and Clinical Excellence (NICE) per l'uso

Wed, February 16, 2011

[ Wed, Feb 16th 2011 ] - Market Wire

Humana Military Announces Employment Partnership with National Industries for the Blind

[ Wed, Feb 16th 2011 ] - Market Wire

Sucanon(R) Type-2 Diabetes Clinical Trials Reach Final Stage in Middle East

[ Wed, Feb 16th 2011 ] - Market Wire

GTSO Rare Earth JV Hires Mongolian Reconnaissance Survey Geological Team

[ Wed, Feb 16th 2011 ] - Market Wire

Microbix Further Strengthens Patent Position for .. &;#8482; -- its Livestock Semen Sexing Technology

[ Wed, Feb 16th 2011 ] - Market Wire

Aberdeen International Reports Value of Investmen .. 3 per Share for Fiscal 2011 Year End (January 31,

[ Wed, Feb 16th 2011 ] - Market Wire

AtriCure Reports Record Fourth Quarter 2010 Financial Results

[ Wed, Feb 16th 2011 ] - Market Wire

Renegade Petroleum Ltd. Announces Strategic Light .. 30 Million Bought Deal Financing and Management C

[ Wed, Feb 16th 2011 ] - Market Wire

Vyteris to Present at the Lippert/Heilshorn Life .. al Technologies Virtual Conference on February 17

[ Wed, Feb 16th 2011 ] - Market Wire

International Stem Cell Demonstrates Progress in .. an Parthenogenetic Stem Cells to Promote the Deve

[ Wed, Feb 16th 2011 ] - Market Wire

Biomoda Receives Notice of Allowance on Patent Application for Method of Analyzing Cancer Cells

[ Wed, Feb 16th 2011 ] - Market Wire

Oncolytics Biotech® Inc. Announces Start of .. nt in Randomized Phase II Pancreatic Cancer Study

[ Wed, Feb 16th 2011 ] - Market Wire

Celgene Elects Michael A. Friedman, MD to Board of Directors

[ Wed, Feb 16th 2011 ] - Market Wire

Syneron Reports Fourth Quarter 2010 Results

[ Wed, Feb 16th 2011 ] - Market Wire

Orthovita Launches Vitossa" Bioactive Foam-2X Bon .. (American Academy of Orthopedic Surgeons) Meeting

[ Wed, Feb 16th 2011 ] - Market Wire

Covidien Announces FDA 510(k) Clearance of New LigaSurea" Instrument

[ Wed, Feb 16th 2011 ] - Market Wire

Derma Sciences to Present at the Lippert/Heilshor .. ences & Medtech Virtual Conference on February 17

Tue, February 15, 2011

[ Tue, Feb 15th 2011 ] - Market Wire

Medivation and Astellas Announce Positive New, Lo .. hase 1-2 Trial of MDV3100 in Advanced Prostate Ca

[ Tue, Feb 15th 2011 ] - Market Wire

Exelixis to Hold February 17th Investor Briefing .. at the ASCO 2011 Genitourinary Cancers Symposium

[ Tue, Feb 15th 2011 ] - Market Wire

Caldolor® Rapid Infusion Shown to be Safe and Well Tolerated in Newly Published Clinical Study

[ Tue, Feb 15th 2011 ] - Market Wire

Five Star Quality Care, Inc. Fourth Quarter Conference Call Scheduled for Tuesday, February 22nd

[ Tue, Feb 15th 2011 ] - Market Wire

Zynex Senior Executive Announces Retirement after 15 Years of Service

[ Tue, Feb 15th 2011 ] - Market Wire

Trinity Biotech Announces Distribution Agreement .. emier Hb9210 Instrument With Menarini Diagnostics

[ Tue, Feb 15th 2011 ] - Market Wire

Alkermes Announces Positive Preliminary Results f .. for Treatment of Opioid-Induced Bowel Dysfunction

[ Tue, Feb 15th 2011 ] - Market Wire

IsoRay, Inc. Announces Second Quarter Fiscal Year 2011 Results

[ Tue, Feb 15th 2011 ] - Market Wire

The World Heart Federation, sanofi-aventis and Bo .. Collaboration on Worldwide AF Awareness Campaign

[ Tue, Feb 15th 2011 ] - Market Wire

Belo Sun Mobilizes a Sixth Drill Rig and Initiate .. uth Block of the Volta Grande Gold Project Brazil

[ Tue, Feb 15th 2011 ] - Market Wire

CONMED Corporation Launches New Products at 2011 .. American Academy of Orthopaedic Surgeons Meeting

[ Tue, Feb 15th 2011 ] - Market Wire

ArthroCare Receives FDA Clearance for Spartan 5.5 Needled Suture Implant

[ Tue, Feb 15th 2011 ] - Market Wire

Covidien to Launch TurboHawka" Plaque Excision System for Small Vessels

[ Tue, Feb 15th 2011 ] - Market Wire

Amedisys Welcomes Julie L. Lewis as Vice President of Health Policy and Government Relations

[ Tue, Feb 15th 2011 ] - Market Wire

Compugen Ltd. Reports Fourth Quarter and Calendar 2010 Financial Results

[ Tue, Feb 15th 2011 ] - Market Wire

Ceregene Reports New Findings Regarding How Parkinson's Brains Respond to Neurotrophic Factors

Mon, February 14, 2011

[ Mon, Feb 14th 2011 ] - Market Wire

The Law Office of Abe Shainberg Launches an Inves .. es of Fiduciary Duty by the Board of Emergency Me

[ Mon, Feb 14th 2011 ] - Market Wire

Cytokinetics, Incorporated Reports Fourth Quarter .. nd Year End Highlights and 2010 Financial Results

[ Mon, Feb 14th 2011 ] - Market Wire

Kendall Law Group Investigates Emergency Medical Services Corporation Acquisition for Shareholders

[ Mon, Feb 14th 2011 ] - Market Wire

Corgenix Reports Second Quarter Fiscal 2011 Financial Results

[ Mon, Feb 14th 2011 ] - Market Wire

Orthovita Schedules Conference Call for Fourth Qu .. Year-End 2010 Financial Results and 2011 Guidance

[ Mon, Feb 14th 2011 ] - Market Wire

CytRx to Receive Shares of ADVENTRX Pharmaceuticals in Exchange for 19% Stake in SynthRx

[ Mon, Feb 14th 2011 ] - Market Wire

Health Net Announces Annual Investor Day to Be Held in New York on February 17, 2011

[ Mon, Feb 14th 2011 ] - Market Wire

BrainStorm Receives FDA Orphan Drug Designation f .. in the Treatment of Amyotrophic Lateral Sclerosis

[ Mon, Feb 14th 2011 ] - Market Wire

Call Genie Inc. Announces Engagement of Wolverton .. Connection With $5,000,000 Convertible Debenture

[ Mon, Feb 14th 2011 ] - Market Wire

Oncolytics Biotech® Inc. Meets Primary Endpo .. of U.S. Phase 2 Pancreatic Cancer Clinical Trial

[ Mon, Feb 14th 2011 ] - Market Wire

BioSante Pharmaceuticals, Inc. To Present LibiGel .. ety Study Update at BIO CEO & Investor Conference

[ Mon, Feb 14th 2011 ] - Market Wire

Inspire Announces Date for Conference Call and We .. er and Full Year 2010 Financial Results and Provi

[ Mon, Feb 14th 2011 ] - Market Wire

AVEO Pharmaceuticalsa? Tivozanib Clinical Data Fe .. at the 2011 ASCO Genitourinary Cancers Symposium

[ Mon, Feb 14th 2011 ] - Market Wire

ArthroCare Reports Fourth Quarter and Full Year 2010 Financial Results

[ Mon, Feb 14th 2011 ] - Market Wire

Medisafe 1 Technologies and McKesson Corp Have Em .. Preliminary Discussions for Potential Cooperation

[ Mon, Feb 14th 2011 ] - Market Wire

Geron to Present at 13th Annual BIO CEO & Investor Conference

Fri, February 11, 2011

[ Fri, Feb 11th 2011 ] - Market Wire

49 Days Left - Kahn Swick & Foti, LLC and Former .. mind Investors With Large Financial Interests (Ov

[ Fri, Feb 11th 2011 ] - Market Wire

Faruqi & Faruqi, LLP Announces Shareholder Invest .. to the Acquisition of RehabCare Group, Inc. - RHB

[ Fri, Feb 11th 2011 ] - Market Wire

MEDWELL CAPITAL REPORTS 2010 YEAR-END RESULTS

[ Fri, Feb 11th 2011 ] - Market Wire

Vertex Announces Webcasts of its Presentations at Two Investor Conferences

[ Fri, Feb 11th 2011 ] - Market Wire

Amedisys Announces Poster Presentation at the Ame .. Therapy Associationa?s Combined Sections Meeting

[ Fri, Feb 11th 2011 ] - Market Wire

ArthroCare Announces Fourth Quarter and Full Year .. s Release and Conference Call Dates and Announces

[ Fri, Feb 11th 2011 ] - Market Wire

Seniors Share Their Love Stories; Celebrate Love Both Early and Late in Life

[ Fri, Feb 11th 2011 ] - Market Wire

Abraham, Fruchter & Twersky, LLP Announces Filing .. Class Action Lawsuit against Mannkind Corporation

[ Fri, Feb 11th 2011 ] - Market Wire

Gilead Sciences vuelve a presentar a la FDA solic .. r©gimen de nico comprimido de Truvada® y TMC278

[ Fri, Feb 11th 2011 ] - Market Wire

American Learning Corporation Reports Third Quarter Results

[ Fri, Feb 11th 2011 ] - Market Wire

NPS Pharmaceuticals to Present at Leerink Swann Hot Topics in Therapeutics Roundtable Conference

[ Fri, Feb 11th 2011 ] - Market Wire

ImmunoCellular Therapeutics to Present at the 13th Annual BIO CEO & Investor Conference

[ Fri, Feb 11th 2011 ] - Market Wire

Inhibitex Receives Fast Track Designation for INX .. r the Treatment of Chronic Hepatitis C Infections

[ Fri, Feb 11th 2011 ] - Market Wire

Gilead Sciences deposita nuovamente la domanda di .. o presso la?ente statunitense preposto al control

[ Fri, Feb 11th 2011 ] - Market Wire

Gilead Sciences erneuert FDA-Zulassungsantrag fr .. Einzeltablettentherapie mit Truvada® und TMC278

[ Fri, Feb 11th 2011 ] - Market Wire

Gilead Sciences deponeert bij de FDA een nieuwe a .. engen van het regime van ©©n tablet Truvada® e

Thu, February 10, 2011

[ Thu, Feb 10th 2011 ] - Market Wire

Cardiovascular Systems Files Special 510(k) for Stealth 360a" Orbital Pad System

[ Thu, Feb 10th 2011 ] - Market Wire

NuVasive and AlloSource Announce Licensing Agreement

[ Thu, Feb 10th 2011 ] - Market Wire

Orthovita Receives FDA Clearance for Vitossa" Bimodal Bone Graft Substitute

[ Thu, Feb 10th 2011 ] - Market Wire

Exactech Announces 2010 Sales of $190.5 Million and 4th Quarter 2010 Sales of $51.8 Million

[ Thu, Feb 10th 2011 ] - Market Wire

Community Health Systems Announces Definitive Agr .. t to Acquire Northeast Pennsylvania Health System

[ Thu, Feb 10th 2011 ] - Market Wire

PATIENT HOME MONITORING ANNOUNCES CEO INTERVIEW ON LEADING BUSINESS RADIO PROGRAM

[ Thu, Feb 10th 2011 ] - Market Wire

Hi-Tech Pharmacal Receives Final Approval for Levofloxacin Ophthalmic Solution

[ Thu, Feb 10th 2011 ] - Market Wire

Fortune 500 Multi-Specialty Health Care Organizat .. orkflow Management Module and New Agent Access Po

[ Thu, Feb 10th 2011 ] - Market Wire

New AVERROES Data Demonstrate Investigational Api .. Reducing Stroke and Systemic Embolism in Patients

[ Thu, Feb 10th 2011 ] - Market Wire

CardioNet,Inc. Appoints Peter Ferola General Coun .. and Senior Vice President, Corporate Development

[ Thu, Feb 10th 2011 ] - Market Wire

Imaging Diagnostic Systems Installs CT laser Mammography system in Indonesia

[ Thu, Feb 10th 2011 ] - Market Wire

GTSO Seeks to Offset Threat of Rare Earth Quotas to U.S. Energy and Defense Industries

[ Thu, Feb 10th 2011 ] - Market Wire

Bard Names Todd W. Garner Vice President, Investor Relations

[ Thu, Feb 10th 2011 ] - Market Wire

Electromed, Inc. Reports 2011 Second Quarter Results

[ Thu, Feb 10th 2011 ] - Market Wire

NuPathe to Present at the Leerink Swann Hot Topics Roundtable Conference

[ Thu, Feb 10th 2011 ] - Market Wire

Pro-Pharmaceuticals Receives Final Tranche of Fun .. Federal Grant; Raises Cash Position to $8 Million

ARIAD to Present at the CITI 2011 Global Healthcare Conference

_{//health-fitness.news-articles.net/content/2011/ .. -the-citi-2011-global-healthcare-conference.html}
^{Published in Health and Fitness on Tuesday, February 22nd 2011 at 4:45 GMT by Market Wire}

CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--[ ARIAD Pharmaceuticals, Inc. ] (NASDAQ: ARIA) today announced that it will present at the CITI 2011 Global Healthcare Conference being held at the Hilton New York Hotel in New York City, New York. Harvey J. Berger, M.D., chairman and chief executive officer at ARIAD, will provide an overview of the Companya�s robust oncology pipeline and progress on its three lead compounds on Tuesday, March 1, at 2 p.m. (ET).

The ARIAD presentation will be webcast live and can be accessed by visiting the investor relations section of the Company's website at [ http://www.ariad.com/investor ]. A replay of the presentation will be available on the ARIAD website approximately one hour after the presentation and will be archived for two weeks.

About ARIAD

ARIAD's vision is to transform the lives of cancer patients with breakthrough medicines. The Company's mission is to discover, develop and commercialize small-molecule drugs to treat cancer in patients with the greatest and most urgent unmet medical need - aggressive cancers where current therapies are inadequate. ARIAD's lead product candidate, ridaforolimus, is an investigational mTOR inhibitor being developed by Merck that has successfully completed a Phase 3 clinical trial in patients with soft-tissue and bone sarcomas and is being studied in multiple cancer indications. ARIAD's second internally discovered product candidate, ponatinib, is an investigational pan-BCR-ABL inhibitor in a pivotal Phase 2 clinical trial in patients with chronic myeloid leukemia and Ph+ acute lymphoblastic leukemia. For additional information, please visit [ www.ariad.com ].

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire